Colgate-Palmolive Company Peer Comparison
Metric | Value | Ranking | ||||||
---|---|---|---|---|---|---|---|---|
Market Cap | $86.9 Billion | 2/6 | PG $407.6B |
CL $86.9B |
KMB $48.0B |
EL $30.2B |
CHD $25.4B |
CLX $20.4B |
Gross Margin | 61% | 1/6 | CL 61% |
EL 56% |
PG 50% |
CLX 46% |
CHD 45% |
KMB 36% |
Profit Margin | 14% | 2/6 | CHD 16% |
CL 14% |
KMB 11% |
CLX 11% |
PG 0% |
EL -6% |
EBITDA margin | 26% | 2/6 | CLX 31% |
CL 26% |
CHD 26% |
PG 19% |
KMB 19% |
EL -5% |
Quarterly Revenue | $5.1 Billion | 2/6 | PG $20.5B |
CL $5.1B |
KMB $5.0B |
EL $5.0B |
CLX $1.9B |
CHD $1.5B |
Quarterly Earnings | $731.0 Million | 1/6 | CL $731.0M |
KMB $544.0M |
CHD $243.5M |
CLX $216.0M |
PG $15.3M |
EL -$284.0M |
Quarterly Free Cash Flow | $873.0 Million | 1/6 | CL $873.0M |
KMB $863.0M |
CHD $206.6M |
PG -$0 |
EL -$0 |
CLX -$0 |
Trailing 4 Quarters Revenue | $20.0 Billion | 3/6 | PG $84.0B |
KMB $20.3B |
CL $20.0B |
EL $16.7B |
CLX $7.1B |
CHD $6.0B |
Trailing 4 Quarters Earnings | $2.8 Billion | 2/6 | PG $20.5B |
CL $5.1B |
KMB $5.0B |
EL $5.0B |
CLX $1.9B |
CHD $1.5B |
Quarterly Earnings Growth | 46% | 2/6 | KMB 1411% |
CL 46% |
CLX 23% |
CHD 10% |
PG -100% |
EL -761% |
Annual Earnings Growth | 76% | 2/6 | CLX 162% |
CL 76% |
KMB 3% |
CHD -3% |
EL -10% |
PG -39% |
Quarterly Revenue Growth | 5% | 1/6 | CL 5% |
CHD 4% |
EL 4% |
PG 0% |
KMB -2% |
CLX -6% |
Annual Revenue Growth | 4% | 1/6 | CL 4% |
PG 4% |
CHD 4% |
EL 4% |
KMB -2% |
CLX -9% |
Cash On Hand | $1.1 Billion | 4/6 | PG $9.5B |
EL $3.4B |
KMB $1.2B |
CL $1.1B |
CHD $491.7M |
CLX $202.0M |
Short Term Debt | $530.0 Million | 3/6 | PG $7.2B |
KMB $806.0M |
CL $530.0M |
CLX $88.0M |
CHD $35.0M |
EL -$0 |
Long Term Debt | $8.1 Billion | 3/6 | PG $25.3B |
EL $9.0B |
CL $8.1B |
KMB $7.2B |
CLX $2.5B |
CHD $2.2B |
PE | 30.59 | 5/6 | EL 77.45 |
CLX 72.98 |
PG 49.07 |
CHD 31.59 |
CL 30.59 |
KMB 26.97 |
PS | 4.35 | 2/6 | PG 4.85 |
CL 4.35 |
CHD 4.23 |
CLX 2.88 |
KMB 2.36 |
EL 1.81 |
PB | 180.27 | 1/6 | CL 180.27 |
CLX 41.53 |
KMB 36.69 |
PG 8.06 |
CHD 5.89 |
EL 5.68 |
PC | 78.28 | 2/6 | CLX 101.16 |
CL 78.28 |
CHD 51.56 |
PG 42.99 |
KMB 41.23 |
EL 8.90 |
Liabilities to Equity | 130.07 | 1/6 | CL 130.07 |
CLX 16.03 |
KMB 14.06 |
EL 3.08 |
PG 1.42 |
CHD 1.04 |
ROA | 0.17 | 1/6 | CL 17% | KMB 10% | CHD 9% | PG 7% | CLX 5% | EL 2% |
ROE | 23.09 | 1/6 | CL 2309% |
KMB 157% |
CLX 85% |
CHD 19% |
PG 16% |
EL 7% |
Current Ratio | 1.03 | 6/6 | CHD 1.97 |
PG 1.70 |
EL 1.32 |
CLX 1.09 |
KMB 1.08 |
CL 1.03 |
Quick Ratio | 0.08 | 4/6 | EL 77.45 |
CLX 72.98 |
PG 49.07 |
CHD 31.59 |
CL 30.59 |
KMB 26.97 |
Long Term Debt to Equity | 66.23 | 1/6 | CL} 66.23 |
CLX} 7.56 |
KMB} 6.30 |
EL} 1.69 |
CHD} 0.51 |
PG} 0.50 |
Debt to Equity | 70.54 | 1/6 | CL 70.54 |
CLX 8.85 |
KMB 7.01 |
EL 1.69 |
PG 0.64 |
CHD 0.56 |
Burn Rate | -4.07 | 5/6 | EL 5.28 |
PG 3.39 |
CLX -2.13 |
CHD -3.36 |
CL -4.07 |
KMB -20.70 |
Cash to Cap | 0.01 | 5/6 | EL 0.11 |
PG 0.02 |
KMB 0.02 |
CHD 0.02 |
CL 0.01 |
CLX 0.01 |
CCR | 1.19 | 2/6 | KMB 1.59 |
CL 1.19 |
CHD 0.85 |
PG 0.00 |
EL 0.00 |
CLX 0.00 |
EV to EBITDA | 71.83 | 2/6 | PG} 110.86 |
CL} 71.83 |
CHD} 70.31 |
KMB} 58.75 |
CLX} 39.68 |
EL} -153.55 |
EV to Revenue | 4.73 | 2/6 | PG 5.12 |
CL 4.73 |
CHD 4.55 |
CLX 3.26 |
KMB 2.70 |
EL 2.14 |